An ambitious study has explored how the oral microbiome may affect our metabolic health, raising hopes that conditions like ...
M Series A to advance MBX-116, a live bacterial product designed to improve immune checkpoint inhibitor response in advanced melanoma.
SOMERVILLE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today ...
A study found that both the low FODMAP diet and rifaximin provide similar relief from IBS symptoms, and gut microbiome ...
Clinical Trials Arena on MSN
EnteroBiotix nets $25m to progress microbiome-based IBS drug
The biotech’s CEO, Dr James McIlroy, says EBX-102-02 could address significant treatment gaps in IBS, which impacts up to 10% of the global population.
Kate Markey, MBBS, PhD, has discovered a link between the intestinal microbiome and developing chronic graft-versus-host ...
Stony Brook University and Ortek Therapeutics, Inc. announced today that two patent applications were filed in the United States and internationally for nutrient based compositions utilizing an ...
Munich, Germany, April 28, 2026 (GLOBE NEWSWIRE) -- mbiomics GmbH, a pioneering techbio company advancing scalable microbiome-based ...
SDG 3 - Ensure healthy lives and promote well-being for all at all ages. The human microbiome has a critical role in health and in a wide range of diseases. There are ongoing preclinical and clinical ...
SARASOTA, FL, UNITED STATES, October 11, 2023 /EINPresswire.com/ -- Biom Pharmaceutical, a leading name in human microbiome technology, unveils its latest innovation ...
Heart failure remains one of the most challenging cardiovascular syndromes to manage, not least because it rarely occurs in isolation. As global populations age, clinicians are caring for increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results